Last 12 months
Inside the activity.
0 purchase rows · 57 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 16 |
| Dec 2025 | 0 | 12 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 8 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 4 |
| Jun 2026 | 0 | 8 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 9 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 21, 2026 Filed Sep 22, 2026 21:16 UTC |
Leite JohnGlobal Chief Commercial Off
|
SaleCommon Stock | 4,015 | $40.00 | $160,600.00 |
DisclosureSEC source: 0001991536-26-000013 · wk-form4_1790111771.xml · nonDerivative · entry 1 Leite John · CIK 0001991536 · Global Chief Commercial Off 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 124,329 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 9, 2026. Read SEC document |
| September 14, 2026 Filed Sep 16, 2026 20:08 UTC |
Holstein JensDirector
|
SaleCommon Stock | 5,000 | $40.95 | $204,747.00 |
DisclosureSEC source: 0001819880-26-000004 · wk-form4_1789589284.xml · nonDerivative · entry 1 Holstein Jens · CIK 0001819880 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 27,471 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 12, 2026. F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $40.57 to $41.40. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| September 04, 2026 Filed Sep 4, 2026 23:54 UTC |
Febbo Phillip G.Chief Scientific & Med Officer
|
SaleCommon Stock | 2,705 | $43.66 | $118,105.17 |
DisclosureSEC source: 0001649245-26-000009 · wk-form4_1788566051.xml · nonDerivative · entry 3 Febbo Phillip G. · CIK 0001649245 · Chief Scientific & Med Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 133,048 F2 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 21, 2025. F4 · price: Represents weighted average sales price. Sale prices for the transactions range from $43.475 to $44.16. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| September 04, 2026 Filed Sep 4, 2026 23:54 UTC |
Febbo Phillip G.Chief Scientific & Med Officer
|
SaleCommon Stock | 10,405 | $42.89 | $446,304.79 |
DisclosureSEC source: 0001649245-26-000009 · wk-form4_1788566051.xml · nonDerivative · entry 2 Febbo Phillip G. · CIK 0001649245 · Chief Scientific & Med Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 135,753 F2 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 21, 2025. F3 · price: Represents weighted average sales price. Sale prices for the transactions range from $42.47 to $43.47. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| September 04, 2026 Filed Sep 4, 2026 23:54 UTC |
Chambers RebeccaChief Financial Officer
|
SaleCommon Stock | 1,175 | $43.71 | $51,363.95 |
DisclosureSEC source: 0001823563-26-000016 · wk-form4_1788566045.xml · nonDerivative · entry 3 Chambers Rebecca · CIK 0001823563 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 166,025 F2 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 21, 2025. F4 · price: Represents weighted average sales price. Sale prices for the transactions range from $43.51 to $44.16. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| September 04, 2026 Filed Sep 4, 2026 23:54 UTC |
Chambers RebeccaChief Financial Officer
|
SaleCommon Stock | 2,477 | $42.81 | $106,030.21 |
DisclosureSEC source: 0001823563-26-000016 · wk-form4_1788566045.xml · nonDerivative · entry 2 Chambers Rebecca · CIK 0001823563 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 167,200 F2 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 21, 2025. F3 · price: Represents weighted average sales price. Sale prices for the transactions range from $42.49 to $43.47. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| September 04, 2026 Filed Sep 4, 2026 23:54 UTC |
McGuire AnnieEVP, General Counsel
|
SaleCommon Stock | 1,100 | $43.67 | $48,038.98 |
DisclosureSEC source: 0001914620-26-000013 · wk-form4_1788566040.xml · nonDerivative · entry 3 McGuire Annie · CIK 0001914620 · EVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 131,160 F3 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 29, 2025. F5 · price: Represents weighted average sales price. Sale prices for the transactions range from $43.50 to $44.16. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| September 04, 2026 Filed Sep 4, 2026 23:54 UTC |
McGuire AnnieEVP, General Counsel
|
SaleCommon Stock | 2,154 | $42.79 | $92,173.11 |
DisclosureSEC source: 0001914620-26-000013 · wk-form4_1788566040.xml · nonDerivative · entry 2 McGuire Annie · CIK 0001914620 · EVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 132,260 F3 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 29, 2025. F4 · price: Represents weighted average sales price. Sale prices for the transactions range from $42.49 to $43.38. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| September 02, 2026 Filed Sep 4, 2026 23:54 UTC |
Wygant JonathanVP, Chief Accounting Officer
|
Tax withholdingCommon Stock | 1,361 | $44.88 | $61,081.68 |
DisclosureSEC source: 0001584145-26-000009 · wk-form4_1788566062.xml · nonDerivative · entry 1 Wygant Jonathan · CIK 0001584145 · VP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,226 F1 · kind: Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of certain restricted stock units on September 2, 2026 and does not represent a sale. F2 · balance_after: Includes 514 shares of common stock purchased on July 31, 2026 pursuant to the Veracyte, Inc. Employee Stock Purchase Plan. Read SEC document |
| September 02, 2026 Filed Sep 4, 2026 23:54 UTC |
Febbo Phillip G.Chief Scientific & Med Officer
|
Tax withholdingCommon Stock | 3,639 | $44.88 | $163,318.32 |
DisclosureSEC source: 0001649245-26-000009 · wk-form4_1788566051.xml · nonDerivative · entry 1 Febbo Phillip G. · CIK 0001649245 · Chief Scientific & Med Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 146,158 F1 · kind: Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of certain restricted stock units on September 2, 2026 and does not represent a sale. Read SEC document |
| September 02, 2026 Filed Sep 4, 2026 23:54 UTC |
Leite JohnGlobal Chief Commercial Off
|
Tax withholdingCommon Stock | 3,961 | $44.88 | $177,769.68 |
DisclosureSEC source: 0001991536-26-000011 · wk-form4_1788566056.xml · nonDerivative · entry 1 Leite John · CIK 0001991536 · Global Chief Commercial Off 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 128,344 F1 · kind: Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of certain restricted stock units on September 2, 2026 and does not represent a sale. Read SEC document |
| September 02, 2026 Filed Sep 4, 2026 23:54 UTC |
Chambers RebeccaChief Financial Officer
|
Tax withholdingCommon Stock | 3,603 | $44.88 | $161,702.64 |
DisclosureSEC source: 0001823563-26-000016 · wk-form4_1788566045.xml · nonDerivative · entry 1 Chambers Rebecca · CIK 0001823563 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 169,677 F1 · kind: Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of certain restricted stock units on September 2, 2026 and does not represent a sale. Read SEC document |
| September 02, 2026 Filed Sep 4, 2026 23:54 UTC |
McGuire AnnieEVP, General Counsel
|
Tax withholdingCommon Stock | 3,215 | $44.88 | $144,289.20 |
DisclosureSEC source: 0001914620-26-000013 · wk-form4_1788566040.xml · nonDerivative · entry 1 McGuire Annie · CIK 0001914620 · EVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 134,414 F1 · kind: Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of certain restricted stock units on September 2, 2026 and does not represent a sale. F2 · balance_after: Includes 389 shares of common stock purchased on July 31, 2026 pursuant to the Veracyte, Inc. Employee Stock Purchase Plan. Read SEC document |
| September 02, 2026 Filed Sep 4, 2026 23:53 UTC |
Stapley MarcDirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 8,782 | $44.88 | $394,136.16 |
DisclosureSEC source: 0001539796-26-000019 · wk-form4_1788566034.xml · nonDerivative · entry 1 Stapley Marc · CIK 0001539796 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 432,073 F1 · kind: Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of certain restricted stock units on September 2, 2026 and does not represent a sale. F2 · balance_after: Includes 361 shares of common stock purchased on July 31, 2026 pursuant to the Veracyte, Inc. Employee Stock Purchase Plan. Read SEC document |
| September 01, 2026 Filed Sep 3, 2026 20:48 UTC |
Bhanji MunaDirector
|
SaleCommon Stock | 1,864 | $42.97 | $80,096.08 |
DisclosureSEC source: 0001846905-26-000006 · wk-form4_1788468511.xml · nonDerivative · entry 1 Bhanji Muna · CIK 0001846905 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 42,718 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 2, 2026. Read SEC document |
| June 18, 2026 Filed Jun 22, 2026 20:30 UTC |
EASTHAM KARINDirector
|
SaleCommon Stock | 529 | $53.55 | $28,328.16 |
DisclosureSEC source: 0001231845-26-000006 · wk-form4_1782160251.xml · nonDerivative · entry 2 EASTHAM KARIN · CIK 0001231845 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,097 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on September 5, 2025. F3 · price: Represents weighted average sales price. Sale prices for the transactions range from $53.29 to $53.70. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| June 18, 2026 Filed Jun 22, 2026 20:30 UTC |
EASTHAM KARINDirector
|
SaleCommon Stock | 3,200 | $52.78 | $168,906.24 |
DisclosureSEC source: 0001231845-26-000006 · wk-form4_1782160251.xml · nonDerivative · entry 1 EASTHAM KARIN · CIK 0001231845 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,626 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on September 5, 2025. F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $52.26 to $53.26. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| June 11, 2026 Filed Jun 15, 2026 20:55 UTC |
Holstein JensDirector
|
GrantCommon Stock | 5,272 | $0.00 | $0.00 |
DisclosureSEC source: 0001819880-26-000002 · wk-form4_1781556948.xml · nonDerivative · entry 1 Holstein Jens · CIK 0001819880 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,471 F1 · kind: Restricted stock units awarded on June 11, 2026 vest in full on the first anniversary of the date of the grant or immediately prior to the Company's next annual meeting of stockholders, if earlier. In addition, the restricted stock units vest in full in the event of a change in control of the Issuer. Read SEC document |
| June 11, 2026 Filed Jun 15, 2026 20:56 UTC |
JONES EVAN/ FADirector
|
GrantCommon Stock | 5,272 | $0.00 | $0.00 |
DisclosureSEC source: 0001020741-26-000002 · wk-form4_1781556970.xml · nonDerivative · entry 1 JONES EVAN/ FA · CIK 0001020741 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,634 F1 · kind: Restricted stock units awarded on June 11, 2026 vest in full on the first anniversary of the date of the grant or immediately prior to the Company's next annual meeting of stockholders, if earlier. In addition, the restricted stock units vest in full in the event of a change in control of the Issuer. Read SEC document |
| June 11, 2026 Filed Jun 15, 2026 20:55 UTC |
Miller Thomas F.Director
|
GrantCommon Stock | 5,272 | $0.00 | $0.00 |
DisclosureSEC source: 0002034921-26-000002 · wk-form4_1781556938.xml · nonDerivative · entry 1 Miller Thomas F. · CIK 0002034921 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,100 F1 · kind: Restricted stock units awarded on June 11, 2026 vest in full on the first anniversary of the date of the grant or immediately prior to the Company's next annual meeting of stockholders, if earlier. In addition, the restricted stock units vest in full in the event of a change in control of the Issuer. Read SEC document |
| June 11, 2026 Filed Jun 15, 2026 20:56 UTC |
Barr EliavDirector
|
GrantCommon Stock | 5,272 | $0.00 | $0.00 |
DisclosureSEC source: 0001940521-26-000002 · wk-form4_1781556958.xml · nonDerivative · entry 1 Barr Eliav · CIK 0001940521 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,461 F1 · kind: Restricted stock units awarded on June 11, 2026 vest in full on the first anniversary of the date of the grant or immediately prior to the Company's next annual meeting of stockholders, if earlier. In addition, the restricted stock units vest in full in the event of a change in control of the Issuer. Read SEC document |
| June 11, 2026 Filed Jun 15, 2026 20:55 UTC |
EPSTEIN ROBERT SDirector
|
GrantCommon Stock | 5,272 | $0.00 | $0.00 |
DisclosureSEC source: 0001252004-26-000004 · wk-form4_1781556952.xml · nonDerivative · entry 1 EPSTEIN ROBERT S · CIK 0001252004 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,718 F1 · kind: Restricted stock units awarded on June 11, 2026 vest in full on the first anniversary of the date of the grant or immediately prior to the Company's next annual meeting of stockholders, if earlier. In addition, the restricted stock units vest in full in the event of a change in control of the Issuer. Read SEC document |
| June 11, 2026 Filed Jun 15, 2026 20:56 UTC |
EASTHAM KARINDirector
|
GrantCommon Stock | 5,272 | $0.00 | $0.00 |
DisclosureSEC source: 0001231845-26-000004 · wk-form4_1781556974.xml · nonDerivative · entry 1 EASTHAM KARIN · CIK 0001231845 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,826 F1 · kind: Restricted stock units awarded on June 11, 2026 vest in full on the first anniversary of the date of the grant or immediately prior to the Company's next annual meeting of stockholders, if earlier. In addition, the restricted stock units vest in full in the event of a change in control of the Issuer. Read SEC document |
| June 11, 2026 Filed Jun 15, 2026 20:56 UTC |
Shafer David BrentDirector
|
GrantCommon Stock | 5,272 | $0.00 | $0.00 |
DisclosureSEC source: 0001728374-26-000004 · wk-form4_1781556964.xml · nonDerivative · entry 1 Shafer David Brent · CIK 0001728374 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,100 F1 · shares: Restricted stock units awarded on June 11, 2026 vest in full on the first anniversary of the date of the grant or immediately prior to the Company's next annual meeting of stockholders, if earlier. In addition, the restricted stock units vest in full in the event of a change in control of the Issuer. Read SEC document |
| June 11, 2026 Filed Jun 15, 2026 20:55 UTC |
Bhanji MunaDirector
|
GrantCommon Stock | 5,272 | $0.00 | $0.00 |
DisclosureSEC source: 0001846905-26-000002 · wk-form4_1781556942.xml · nonDerivative · entry 1 Bhanji Muna · CIK 0001846905 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,582 F1 · kind: Restricted stock units awarded on June 11, 2026 vest in full on the first anniversary of the date of the grant or immediately prior to the Company's next annual meeting of stockholders, if earlier. In addition, the restricted stock units vest in full in the event of a change in control of the Issuer. Read SEC document |
| June 04, 2026 Filed Jun 5, 2026 01:38 UTC |
McGuire AnnieEVP, General Counsel
|
SaleCommon Stock | 1,776 | $50.12 | $89,007.44 |
DisclosureSEC source: 0001914620-26-000011 · wk-form4_1780623529.xml · nonDerivative · entry 3 McGuire Annie · CIK 0001914620 · EVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 137,240 F2 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 29, 2025. F4 · price: Represents weighted average sales price. Sale prices for the transactions range from $49.89 to $50.40. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| June 04, 2026 Filed Jun 5, 2026 01:38 UTC |
McGuire AnnieEVP, General Counsel
|
SaleCommon Stock | 1,400 | $49.31 | $69,028.54 |
DisclosureSEC source: 0001914620-26-000011 · wk-form4_1780623529.xml · nonDerivative · entry 2 McGuire Annie · CIK 0001914620 · EVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 139,016 F2 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 29, 2025. F3 · price: Represents weighted average sales price. Sale prices for the transactions range from $48.84 to $49.84. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| June 04, 2026 Filed Jun 5, 2026 01:38 UTC |
Chambers RebeccaChief Financial Officer
|
SaleCommon Stock | 1,961 | $50.09 | $98,229.04 |
DisclosureSEC source: 0001823563-26-000014 · wk-form4_1780623518.xml · nonDerivative · entry 3 Chambers Rebecca · CIK 0001823563 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 173,280 F2 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 21, 2025. F4 · price: Represents weighted average sales price. Sale prices for the transactions range from $49.88 to $50.40. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| June 04, 2026 Filed Jun 5, 2026 01:38 UTC |
Chambers RebeccaChief Financial Officer
|
SaleCommon Stock | 1,600 | $49.28 | $78,853.76 |
DisclosureSEC source: 0001823563-26-000014 · wk-form4_1780623518.xml · nonDerivative · entry 2 Chambers Rebecca · CIK 0001823563 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 175,241 F2 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 21, 2025. F3 · price: Represents weighted average sales price. Sale prices for the transactions range from $48.80 to $49.74. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| June 04, 2026 Filed Jun 5, 2026 01:38 UTC |
Stapley MarcDirector · Chief Executive Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 138,051 | $0.00 Strike: $36.60 | $0.00 |
DisclosureSEC source: 0001539796-26-000015 · wk-form4_1780623504.xml · derivative · entry 4 Stapley Marc · CIK 0001539796 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 138,051 shares Expires 2031-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 24, 2025. F5 · derivative.exercise_date: The option is fully vested. Read SEC document |
| June 04, 2026 Filed Jun 5, 2026 01:38 UTC |
Stapley MarcDirector · Chief Executive Officer
|
SaleCommon Stock | 138,051 | $50.12 | $6,919,585.49 |
DisclosureSEC source: 0001539796-26-000015 · wk-form4_1780623504.xml · nonDerivative · entry 3 Stapley Marc · CIK 0001539796 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 440,494 F3 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 24, 2025. F4 · price: Represents weighted average sales price. Sale prices for the transactions range from $50.00 to $50.52. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| June 04, 2026 Filed Jun 5, 2026 01:38 UTC |
Stapley MarcDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 138,051 | $36.60 | $5,052,666.60 |
DisclosureSEC source: 0001539796-26-000015 · wk-form4_1780623504.xml · nonDerivative · entry 2 Stapley Marc · CIK 0001539796 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 578,545 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 24, 2025. Read SEC document |
| June 04, 2026 Filed Jun 5, 2026 01:38 UTC |
Leite JohnGlobal Chief Commercial Off
|
SaleCommon Stock | 13,975 | $50.07 | $699,732.44 |
DisclosureSEC source: 0001991536-26-000009 · wk-form4_1780623498.xml · nonDerivative · entry 2 Leite John · CIK 0001991536 · Global Chief Commercial Off 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 132,305 F2 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 9, 2025. F3 · price: Represents weighted average sales price. Sale prices for the transactions range from $50.00 to $50.30. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| June 02, 2026 Filed Jun 5, 2026 01:38 UTC |
McGuire AnnieEVP, General Counsel
|
Tax withholdingCommon Stock | 3,292 | $47.80 | $157,357.60 |
DisclosureSEC source: 0001914620-26-000011 · wk-form4_1780623529.xml · nonDerivative · entry 1 McGuire Annie · CIK 0001914620 · EVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 140,416 F1 · kind: Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of certain restricted stock units on June 2, 2026 and does not represent a sale. Read SEC document |
| June 02, 2026 Filed Jun 5, 2026 01:38 UTC |
Chambers RebeccaChief Financial Officer
|
Tax withholdingCommon Stock | 3,693 | $47.80 | $176,525.40 |
DisclosureSEC source: 0001823563-26-000014 · wk-form4_1780623518.xml · nonDerivative · entry 1 Chambers Rebecca · CIK 0001823563 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 176,841 F1 · kind: Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of certain restricted stock units on June 2, 2026 and does not represent a sale. Read SEC document |
| June 02, 2026 Filed Jun 5, 2026 01:38 UTC |
Wygant JonathanVP, Chief Accounting Officer
|
Tax withholdingCommon Stock | 1,361 | $47.80 | $65,055.80 |
DisclosureSEC source: 0001584145-26-000007 · wk-form4_1780623524.xml · nonDerivative · entry 1 Wygant Jonathan · CIK 0001584145 · VP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,073 F1 · kind: Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of certain restricted stock units on June 2, 2026 and does not represent a sale. Read SEC document |
| June 02, 2026 Filed Jun 5, 2026 01:38 UTC |
Febbo Phillip G.Chief Scientific & Med Officer
|
Tax withholdingCommon Stock | 3,730 | $47.80 | $178,294.00 |
DisclosureSEC source: 0001649245-26-000007 · wk-form4_1780623512.xml · nonDerivative · entry 1 Febbo Phillip G. · CIK 0001649245 · Chief Scientific & Med Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 149,797 F1 · kind: Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of certain restricted stock units on June 2, 2026 and does not represent a sale. Read SEC document |
| June 02, 2026 Filed Jun 5, 2026 01:38 UTC |
Stapley MarcDirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 9,012 | $47.80 | $430,773.60 |
DisclosureSEC source: 0001539796-26-000015 · wk-form4_1780623504.xml · nonDerivative · entry 1 Stapley Marc · CIK 0001539796 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 440,494 F1 · kind: Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of certain restricted stock units on June 2, 2026 and does not represent a sale. F2 · balance_after: Due to an administrative error, shares of common stock acquired by the Reporting Person under the Veracyte, Inc. Employee Stock Purchase Plan on July 31, 2025 were incorrectly reported as 529 shares of common stock instead of 382 shares of common stock in a Form 4 filed on September 4, 2025, and these shares were overreported in subsequent Forms 4 filed by the Reporting Person. This column reflects the corrected balance. Read SEC document |
| June 02, 2026 Filed Jun 5, 2026 01:38 UTC |
Leite JohnGlobal Chief Commercial Off
|
Tax withholdingCommon Stock | 4,059 | $47.80 | $194,020.20 |
DisclosureSEC source: 0001991536-26-000009 · wk-form4_1780623498.xml · nonDerivative · entry 1 Leite John · CIK 0001991536 · Global Chief Commercial Off 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 146,280 F1 · kind: Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of certain restricted stock units on June 2, 2026 and does not represent a sale. Read SEC document |
| May 22, 2026 Filed May 27, 2026 20:19 UTC |
Wygant JonathanVP, Chief Accounting Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 24,000 | $0.00 Strike: $24.80 | $0.00 |
DisclosureSEC source: 0001584145-26-000006 · wk-form4_1779913148.xml · derivative · entry 3 Wygant Jonathan · CIK 0001584145 · VP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 24,000 shares Expires 2032-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option is fully vested. Read SEC document |
| May 22, 2026 Filed May 27, 2026 20:19 UTC |
Wygant JonathanVP, Chief Accounting Officer
|
SaleCommon Stock | 24,000 | $45.40 | $1,089,624.00 |
DisclosureSEC source: 0001584145-26-000006 · wk-form4_1779913148.xml · nonDerivative · entry 2 Wygant Jonathan · CIK 0001584145 · VP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,434 F1 · price: Represents weighted average sales price. Sale prices for the transactions range from $45.07 to $45.69. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| May 22, 2026 Filed May 27, 2026 20:19 UTC |
Wygant JonathanVP, Chief Accounting Officer
|
Exercise / conversionCommon Stock | 24,000 | $24.80 | $595,200.00 |
DisclosureSEC source: 0001584145-26-000006 · wk-form4_1779913148.xml · nonDerivative · entry 1 Wygant Jonathan · CIK 0001584145 · VP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,434 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 20, 2026 Filed May 22, 2026 20:39 UTC |
EPSTEIN ROBERT SDirector
|
SaleCommon Stock | 10,000 | $44.01 | $440,129.00 |
DisclosureSEC source: 0001252004-26-000002 · wk-form4_1779482346.xml · nonDerivative · entry 1 EPSTEIN ROBERT S · CIK 0001252004 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 52,446 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on December 5, 2025. F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $44.00 to $44.10. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| May 06, 2026 Filed May 8, 2026 20:25 UTC |
McGuire AnnieSVP, General Counsel
|
SaleCommon Stock | 5,102 | $40.00 | $204,080.00 |
DisclosureSEC source: 0001914620-26-000010 · wk-form4_1778271897.xml · nonDerivative · entry 2 McGuire Annie · CIK 0001914620 · SVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 143,708 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 29, 2025. Read SEC document |
| May 06, 2026 Filed May 8, 2026 20:25 UTC |
McGuire AnnieSVP, General Counsel
|
SaleCommon Stock | 5,102 | $38.05 | $194,131.10 |
DisclosureSEC source: 0001914620-26-000010 · wk-form4_1778271897.xml · nonDerivative · entry 1 McGuire Annie · CIK 0001914620 · SVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 148,810 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 29, 2025. Read SEC document |
| April 10, 2026 Filed Apr 14, 2026 21:03 UTC |
Haas Kevin RichardChief Dev and Tech Officer
|
GrantCommon Stock | 44,221 | $0.00 | $0.00 |
DisclosureSEC source: 0001843872-26-000011 · wk-form4_1776200598.xml · nonDerivative · entry 1 Haas Kevin Richard · CIK 0001843872 · Chief Dev and Tech Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,221 F1 · kind: Restricted stock units awarded on April 10, 2026 vest 25% on June 2, 2027 and 1/16 per quarter thereafter subject to continuing employment of the Reporting Person on each vesting date. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 21:10 UTC |
McGuire AnnieSVP, General Counsel
|
GrantCommon Stock | 26,314 | $0.00 | $0.00 |
DisclosureSEC source: 0001914620-26-000008 · wk-form4_1773177022.xml · nonDerivative · entry 2 McGuire Annie · CIK 0001914620 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 153,912 F2 · kind: Restricted stock units awarded on March 6, 2026 vest in full on the first anniversary of the date of grant subject to continuing employment of the Reporting Person on each vesting date. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 21:10 UTC |
McGuire AnnieSVP, General Counsel
|
GrantCommon Stock | 32,892 | $0.00 | $0.00 |
DisclosureSEC source: 0001914620-26-000008 · wk-form4_1773177022.xml · nonDerivative · entry 1 McGuire Annie · CIK 0001914620 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 127,598 F1 · kind: Restricted stock units awarded on March 6, 2026 vest 25% on March 2, 2027 and 1/16 per quarter thereafter subject to continuing employment of the Reporting Person on each vesting date. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 21:10 UTC |
Wygant JonathanVP, Chief Accounting Officer
|
GrantCommon Stock | 10,525 | $0.00 | $0.00 |
DisclosureSEC source: 0001584145-26-000004 · wk-form4_1773177026.xml · nonDerivative · entry 1 Wygant Jonathan · CIK 0001584145 · VP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,434 F1 · kind: Restricted stock units awarded on March 6, 2026 vest 25% on March 2, 2027 and 1/16 per quarter thereafter subject to continuing employment of the Reporting Person on each vesting date. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 21:10 UTC |
Febbo Phillip G.Chief Scientific & Med Officer
|
GrantCommon Stock | 6,578 | $0.00 | $0.00 |
DisclosureSEC source: 0001649245-26-000006 · wk-form4_1773177016.xml · nonDerivative · entry 2 Febbo Phillip G. · CIK 0001649245 · Chief Scientific & Med Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 153,527 F2 · kind: Restricted stock units awarded on March 6, 2026 vest in full on the first anniversary of the date of grant subject to continuing employment of the Reporting Person on each vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.